Related Experiment Video
Updated: Jul 7, 2026

Visualizing Methane-Cycling Microbial Dynamics in Coastal Wetlands
Published on: January 31, 2025
The effect of pharmaceuticals on the kinetics of methanogenesis and acetogenesis
M S Fountoulakis1, K Stamatelatou, G Lyberatos
1Laboratory of Biochemical Engineering and Environmental Technology, Department of Chemical Engineering, University of Patras, University Campus, Rio, GR-26500 Patras, Greece. m_fountoul@chemeng.upatras.gr
Abstract:
In this study, the widely used anaerobic digestion model (ADM1) was used in order to simulate the inhibition of three pharmaceuticals, propranolol hydrochloride, ofloxacin and diclofenac sodium, on two groups of microorganisms, acetogens and acetoclastic methanogens, the most sensitive microorganisms groups involved in the anaerobic digestion process. The specific maximum consumption rate and saturation constant of acetate and propionate degraders were estimated through fitting the model to experimental data taken from continuous and batch experiments. A modified non-competitive inhibition function was used, and the inhibition constants were estimated using data from Batch experiments conducted at various concentrations of pharmaceuticals using enriched cultures with propionate and acetate degraders. It was found that propranolol hydrochloride was the most inhibitory pharmaceutical to both microorganisms groups.
Insights
Propranolol hydrochloride, ofloxacin, and diclofenac sodium were studied for their impact on anaerobic digestion. Propranolol hydrochloride showed the strongest inhibition of key microorganisms involved in the process.
Area of Science:
- Environmental microbiology
- Biochemical engineering
- Wastewater treatment
Background:
- Pharmaceuticals in wastewater pose risks to microbial processes.
- Anaerobic digestion is crucial for organic waste treatment.
- Acetogens and acetoclastic methanogens are sensitive to contaminants.
Purpose of the Study:
- To simulate the inhibitory effects of propranolol hydrochloride, ofloxacin, and diclofenac sodium on anaerobic digestion.
- To quantify the impact of these pharmaceuticals on acetogens and acetoclastic methanogens.
- To estimate inhibition constants for pharmaceutical compounds.
Main Methods:
- Utilized the anaerobic digestion model (ADM1) for simulations.
- Estimated kinetic parameters (maximum consumption rate, saturation constant) by fitting ADM1 to experimental data.
- Employed a modified non-competitive inhibition function to determine inhibition constants from batch experiments at varying pharmaceutical concentrations.
Main Results:
- Propranolol hydrochloride exhibited the most significant inhibitory effect on both acetogens and acetoclastic methanogens.
- Kinetic parameters for acetate and propionate degraders were successfully estimated.
- Inhibition constants were determined for the tested pharmaceuticals.
Conclusions:
- Propranolol hydrochloride poses the highest risk to anaerobic digestion efficiency among the tested pharmaceuticals.
- The ADM1 model, with modified inhibition functions, is effective for assessing pharmaceutical impacts.
- Understanding pharmaceutical inhibition is vital for maintaining effective wastewater treatment processes.
Related Concept Videos
Microbes and Methanogenesis
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in determining the metabolic...
Overview of Archaea
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Metabolism of Chemolithotrophs
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

